Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation [NA]

View source ↗

Summary

This clinical trial update notes an ongoing study evaluating psychotherapy combined with intranasal esketamine for suicidal ideation, with enrollment by invitat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: University of California, San Diego | Conditions: Suicidal Ideation | NA | Status: ENROLLING_BY_INVITATION